Filing Details

Accession Number:
0001477932-17-003817
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-10 18:07:34
Reporting Period:
2017-08-08
Filing Date:
2017-08-10
Accepted Time:
2017-08-10 18:07:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1506251 Citius Pharmaceuticals Inc. CTXR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463414 L Leonard Mazur C//O Citius Pharmaceuticals, Inc.
11 Commerce Drive, 1St Floor
Cranford NJ 07016
Executive Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-08 421,400 $4.13 1,779,663 No 4 P Direct
Common Stock Acquisiton 2017-08-08 1,547,067 $3.09 3,326,730 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2017-08-08 421,400 $0.01 421,400 $4.13
Common Stock Convertible Promissory Note Acquisiton 2017-08-08 1,547,067 $0.00 1,547,067 $3.09
Common Stock Convertible Promissory Note Disposition 2017-08-08 1,547,067 $0.00 1,547,067 $3.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
421,400 2018-02-08 2022-08-08 No 4 P Direct
1,547,067 2017-08-08 2017-12-31 No 4 A Direct
0 2017-08-08 2017-12-31 No 4 C Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrant to Purchase Common Stock $6.15 2019-06-12 19,614 19,614 Direct
Common Stock Warrant to Purchase Common Stock $9.90 2019-09-30 3,171 3,171 Direct
Common Stock Warrant to Purchase Common Stock $9.90 2020-01-08 4,984 4,984 Direct
Common Stock Warrant to Purchase Common Stock $7.50 2020-08-18 35,211 35,211 Direct
Common Stock Warrant to Purchase Common Stock $7.50 2020-11-02 20,783 20,783 Direct
Common Stock Warrant to Purchase Common Stock $7.50 2020-11-20 20,664 20,664 Direct
Common Stock Warrant to Purchase Common Stock $7.50 2021-01-08 13,679 13,679 Direct
Common Stock Warrant to Purchase Common Stock $7.50 2021-03-14 4,210 4,210 Direct
Common Stock Warrant to Purchase Common Stock $6.15 2021-03-15 18,106 18,106 Direct
Common Stock Options to Purchase Common Stock $6.75 2024-09-12 220,000 220,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-06-12 19,614 19,614 Direct
2019-09-30 3,171 3,171 Direct
2020-01-08 4,984 4,984 Direct
2020-08-18 35,211 35,211 Direct
2020-11-02 20,783 20,783 Direct
2020-11-20 20,664 20,664 Direct
2021-01-08 13,679 13,679 Direct
2021-03-14 4,210 4,210 Direct
2021-03-15 18,106 18,106 Direct
2024-09-12 220,000 220,000 Direct
Footnotes
  1. On August 8, 2017, the Reporting Person purchased a five-year warrant to purchase 421,400 shares of the Company's common stock at an exercise price of $4.125 per share. The warrant is fully vested and exercisable six months from August 8, 2017.
  2. On August 8, 2017, the Reporting Person converted $4,710,000 of outstanding convertible promissory notes and accrued interest of $76,240 into shares of common stock at a conversion price per share of $3.09, which was 75% of the price per share paid by investors in the Company's public offering that was completed on August 8, 2017 as set forth in the terms of the convertible promissory notes.
  3. The warrant is fully vested and exercisable immediately.
  4. The option vests as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017. The option was issued pursuant to the Company's 2014 Stock Incentive Plan.